In the high-stakes world of drug discovery, where failure rates exceed 90% and timelines stretch over a decade, AQEMIA is rewriting the rules. By fusing physics-based simulations with generative AI, they're not just predicting molecules—they're inventing them from scratch.

"Traditional AI models predict what's known. AQEMIA's physics engine invents what's never existed."

The technical stack reveals their modern approach: Next.js for the frontend, Netlify for deployment, and Storyblok for content management. But the real magic happens under the hood—a proprietary blend of molecular dynamics and generative adversarial networks that respects quantum mechanical principles. It's not just AI; it's AI with a physics PhD.

• Physics-informed generative models that respect chemical laws from day one
• Full-stack platform from target identification to lead optimization
• Oncology-first strategy with 3+ undisclosed programs in the pipeline
• 83-person team with deep expertise in medicinal chemistry and ML engineering